The U.S. IV Solution market was valued at nearly $2.1 billion after experiencing double-digit growth in 2024. This is expected to continue to increase over the forecast period at a CAGR of 5.8% to reach nearly $2.8 billion by 2029.
The IV solutions market includes several key product segments: IV fluids, drug reconstitution solutions, irrigation solutions, multi-electrolyte solutions, and other specialized IV fluids. Among these, IV fluids consistently held the largest share of the total market during the historical period, largely due to their essential role in hydration and medication delivery. However, the drug reconstitution and irrigation solutions segments have become the fastest-growing categories, both achieving high single-digit growth rates due to increased procedural complexity, rising safety standards, and the growing use of injectable therapies. Conversely, the "other" segment has recorded negative growth, impacted by lower utilization rates and shifting clinical preferences.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Company Profiles and Product Portfolios
- Leading Competitors
U.S. IV SOLUTIONS MARKET TRENDS
- The market posted only modest growth in 2023, as purchasing stabilized and providers adjusted to macroeconomic headwinds. Despite this lull, 2024 marked a renewed acceleration, with growth rebounding due to increased procedural volumes, renewed investment in hospital and alternate care infrastructure, and rising demand in outpatient and home care settings.
- Looking ahead, the market is expected to grow steadily throughout the forecast period, with growth supported by a combination of rising global healthcare demand, improvements in fluid formulations and packaging, and an increasing shift toward decentralized care.
U.S. IV SOLUTIONS MARKET SHARE INSIGHTS
1. Baxter - Market Leader
- Held the highest market share across all primary segments: IV fluids, irrigation solutions, drug reconstitution, and multi-electrolyte formulations.
- Leadership supported by manufacturing capacity, broad product portfolio, and strong GPO relationships.
- Does not compete in the "other" category.
2. B. Braun - Second-Largest Competitor
- Active in every major segment except the "other" category.
- Positioned as a strong alternative to Baxter, focusing on consistent supply and U.S.-based manufacturing.
3. ICU Medical - Third-Largest Competitor
- Present in all major segments, including the "other" category.
- Holds dominant share in the "other" category through specialized and niche fluid products.
MARKET SEGMENTATION SUMMARY
Total IV Solution Market - Further Segmented Into:
- Bag Size: Large Bags and Small Bags
- Premix: Premix and Non-Premix
- Volume: 1-200 mL, 201-999 mL, 1000-2000 mL, and 2000+ mL
- Container Type: Bag, Bottle, and Other
- IV Solutions Market
- Irrigation Solutions Market
- Drug Reconstitution Market
- Multi-Electrolyte Market
- Other Markets
RESEARCH SCOPE SUMMARY
Regions: United States
Base Year: 2024
Forecast Period: 2025-2029
Historical Data: 2019-2023
Quantitative Coverage:
- Market Size
- Market Shares
- Market Forecasts
- Market Growth Rates
- Units Sold
- Average Selling Prices
Qualitative Coverage:
- Market Growth Trends
- Market Limiters
- Competitive Analysis & SWOT for Top Competitors
- Mergers & Acquisitions
- Company Profiles
- Product Portfolios
- FDA Recalls
- Disruptive Technologies
- Disease Overviews
Data Sources:
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database